Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

32
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
32
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

4.7K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.7K
Pharmacokinetics: Overview01:10

Pharmacokinetics: Overview

11.4K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
11.4K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

525
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
525
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

5.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guselkumab - In Psoriasis and Beyond.

Dermatology practical & conceptual·2024
Same author

Comparison of the clinical efficacy of topical tretinoin 0.05% cream and tacrolimus 0.1% ointment plus iontophoresis in the management of palmoplantar psoriasis.

Clinical and experimental dermatology·2024
Same author

Saxophone penis: A sequel to penoscrotal hidradenitis suppurativa.

Indian journal of sexually transmitted diseases and AIDS·2023
Same author

Giant Solitary Trichoepithelioma: A Diagnosis of Exclusion.

International journal of trichology·2023
Same author

Penile lichen planus mimicking psoriasis clinically and delineating two different patterns on histopathology.

Indian journal of sexually transmitted diseases and AIDS·2022
Same author

A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.

Dermatologic therapy·2022
Same journal

Severe Irritant Contact Dermatitis to <i>Cyperus Scariosus</i>: A Side Effect of Ayurvedic <i>Plava</i>.

Indian journal of dermatology·2026
Same journal

Extensive Grouped Papules on the Vulva in a Patient with Cervical Cancer.

Indian journal of dermatology·2026
Same journal

Facial Melanosis: A Comprehensive Review of Uncommon and Common Presentations with Personal Experience.

Indian journal of dermatology·2026
Same journal

Exploring AI as a Diagnostic Tool in Medical Imaging for Dermatopathological Diseases.

Indian journal of dermatology·2026
Same journal

Carotid Intima-Media Thickness and Retrobulbar Blood Flow in Patients with Psoriasis.

Indian journal of dermatology·2026
Same journal

Pyoderma Gangrenosum-Like Ulcer Secondary to Antiphospholipid Syndrome.

Indian journal of dermatology·2026
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

Assembly and Purification of Prototype Foamy Virus Intasomes
10:20

Assembly and Purification of Prototype Foamy Virus Intasomes

Published on: March 19, 2018

6.0K

Vorinostat-An Overview.

Aditya Kumar Bubna1

  • 1Consultant Dermatologist, Kedar Hospital, Chennai, Tamil Nadu, India.

Indian Journal of Dermatology
|August 20, 2015
PubMed
Summary
This summary is machine-generated.

Vorinostat is an effective and well-tolerated drug for managing cutaneous T-cell lymphoma that persists or worsens after other treatments. Its potential in treating other cancers is currently under investigation.

Keywords:
Cutaneous T cell lymphomaVorinostathistone deacytelase inhibitor

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.7K
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

9.4K

Related Experiment Videos

Last Updated: Apr 5, 2026

Assembly and Purification of Prototype Foamy Virus Intasomes
10:20

Assembly and Purification of Prototype Foamy Virus Intasomes

Published on: March 19, 2018

6.0K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.7K
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

9.4K

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Cutaneous T-cell lymphoma (CTCL) management presents challenges, especially for refractory or progressive disease.
  • Vorinostat is an emerging therapeutic agent with a demonstrated role in specific cancer contexts.

Purpose of the Study:

  • To summarize the role of Vorinostat in managing cutaneous T-cell lymphoma.
  • To highlight its efficacy and tolerability in this patient population.
  • To note ongoing investigations into its use for other cancer types.

Main Methods:

  • Literature review of clinical studies and trials involving Vorinostat.
  • Analysis of efficacy and safety data for Vorinostat in CTCL.
  • Overview of current research exploring Vorinostat in other malignancies.

Main Results:

  • Vorinostat demonstrates efficacy in patients with persistent, progressive, or relapsed CTCL.
  • The drug is generally well-tolerated, positioning it as a novel treatment option.
  • Pre-clinical and clinical investigations are exploring Vorinostat's utility in various cancers.

Conclusions:

  • Vorinostat is a valuable therapeutic option for advanced cutaneous T-cell lymphoma.
  • Its established efficacy and favorable safety profile support its use.
  • Further research is warranted to expand the application of Vorinostat in broader oncological settings.